PTCT
PTC Therapeutics Inc
Price:  
25.94 
USD
Volume:  
649,185.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT EV/EBITDA

-285.9%
Upside

As of 2024-02-22, the EV/EBITDA ratio of PTC Therapeutics Inc (PTCT) is -19.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PTCT's latest enterprise value is 3,148.53 mil USD. PTCT's TTM EBITDA according to its financial statements is -157.64 mil USD. Dividing these 2 quantities gives us the above PTCT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.9x - 18.2x 14.0x
Forward P/E multiples 16.1x - 18.3x 17.0x
Fair Price (49.42) - (53.76) (48.22)
Upside -290.5% - -307.3% -285.9%
25.94 USD
Stock Price
(48.22) USD
Fair Price

PTCT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-22 -3.06
2024-02-21 -3.05
2024-02-20 -3.05
2024-02-16 -3.05
2024-02-15 -3.02
2024-02-14 -2.94
2024-02-13 -2.84
2024-02-12 -3.05
2024-02-09 -3.00
2024-02-08 -2.97
2024-02-07 -2.97
2024-02-06 -3.15
2024-02-05 -2.95
2024-02-02 -2.96
2024-02-01 -3.06
2024-01-31 -3.07
2024-01-30 -3.12
2024-01-29 -3.31
2024-01-26 -3.18
2024-01-25 -3.13
2024-01-24 -3.20
2024-01-23 -3.29
2024-01-22 -3.21
2024-01-19 -3.18
2024-01-18 -3.21
2024-01-17 -3.30
2024-01-16 -3.37
2024-01-12 -3.21
2024-01-11 -3.38
2024-01-10 -3.39
2024-01-09 -3.38
2024-01-08 -3.53
2024-01-05 -3.28
2024-01-04 -3.30
2024-01-03 -3.20
2024-01-02 -3.30
2023-12-29 -3.24
2023-12-28 -3.36
2023-12-27 -3.45
2023-12-26 -3.35
2023-12-22 -3.25
2023-12-21 -3.34
2023-12-20 -3.18
2023-12-19 -3.25
2023-12-18 -3.24
2023-12-15 -3.34
2023-12-14 -3.25
2023-12-13 -3.28
2023-12-12 -3.07
2023-12-11 -3.04